PEGylation Enhances Colloidal Stability and Promotes Ligand-Mediated Targeting of LAF–Xenopeptide mRNA Complexes

For complexation of mRNA into polyplexes, double-pH-responsive lipo-xenopeptides (XP), comprising tetraethylene pentamino succinic acid (Stp) and lipoamino fatty acids (LAFs), were combined with PEGylated lipids, either DMG-PEG 2 kDa (DMG-PEG) or azido-group-containing DSPE-PEG 2 kDa (DSPE-PEG-N3), to increase colloidal stability and to facilitate ligand-mediated targeted mRNA delivery. LAF-XPs mixed with DMG-PEG at low (1.5% and 3%) molar ratios improved colloidal stability and retained transfection efficiency. PEGylation also enabled the formulation of otherwise unstable carrier complexes and prevented aggregation induced by salt, proteins, and serum. PEGylation of more positively charged Stp-LAF2 mRNA polyplexes decreased fibrinogen adsorption. More neutral, LAF-rich Stp-LAF4 polyplexes exhibited low fibrinogen binding without PEGylation. Intravenous administration of these stabilized mRNA complexes demonstrated enhanced biosafety while preserving transfection efficiency. DSPE-PEG-N3 was selected for cell targeting after strain-promoted azide-alkyne cycloaddition (SPAAC)-mediated click-coupling of DBCO-modified ligands. Higher PEG ratios (10% and 20%) provided effective shielding but reduced transfection efficiency, a drawback known as the “PEG dilemma”. Functionalization with an EGFR-targeting ligand restored transfection in EGFR-positive cell lines in a ligand-specific manner. High transfection efficiency is consistent with a lipophilic-to-hydrophilic polarity switch of LAF-XP carriers upon endosomal protonation, triggering dissociation of the PEG lipids and deshielding of the polyplex.

• Publication year

  2025

• Venue

  Polymers

• Publication date

  2025-11-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3390/polym17222979PMID 41304345PMCID 12656170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD47 Peptide-Cloaked Lipid Nanoparticles Promote Cell-Specific mRNA Delivery.

  2025cited by this paper
• Binary Copolymer Blending Enhances pDNA Delivery Performance and Colloidal Shelf Stability of Quinine-Based Polyplexes.

  2025cited by this paper
• Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with Polyneuropathy.

  2025cited by this paper
• Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo

  2025cited by this paper
• Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles

  2025cited by this paper
• Engineered protein corona sustains stealth functionality of nanocarriers in plasma

  2025cited by this paper
• Nanobody‐Decorated Lipid Nanoparticles for Enhanced mRNA Delivery to Tumors In Vivo

  2025cited by this paper
• The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery.

  2025cited by this paper
• Lung‐Specific mRNA Delivery by Ionizable Lipids with Defined Structure‐Function Relationship and Unique Protein Corona Feature

  2025cited by this paper
• Next-generation materials for nucleic acid delivery

  2025cited by this paper
• Modulating efficacy and cytotoxicity of lipoamino fatty acid nucleic acid carriers using disulfide or hydrophobic spacers.

  2024cited by this paper
• Recent advances in nanoparticulate RNA delivery systems

  2024cited by this paper
• Dynamic carriers for therapeutic RNA delivery

  2024cited by this paper
• The 60-year evolution of lipid nanoparticles for nucleic acid delivery

  2024cited by this paper
• Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro.

  2024cited by this paper
• Adeno-associated virus as a delivery vector for gene therapy of human diseases

  2024cited by this paper
• Polysarcosine functionalised cationic polyesters efficiently deliver self-amplifying mRNA

  2024cited by this paper
• Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose.

  2024cited by this paper
• In Vivo Endothelial Cell Gene Silencing by siRNA-LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting.

  2024cited by this paper
• pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function

  2023cited by this paper
• Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity.

  2023cited by this paper
• Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury

  2023cited by this paper
• Molecular Chameleon Carriers for Nucleic Acid Delivery: The Sweet Spot between Lipoplexes and Polyplexes

  2023influential reference
• High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo.

  2023cited by this paper
• Stealth and pseudo-stealth nanocarriers.

  2023cited by this paper
• The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles.

  2023cited by this paper
• Polyethylenimine (PEI) in gene therapy: Current status and clinical applications.

  2023cited by this paper
• Poly(2-oxazoline)-based polyplexes as a PEG-free plasmid DNA delivery platform

  2022cited by this paper
• Performance of nanoparticles for biomedical applications: The in vitro/in vivo discrepancy.

  2022cited by this paper
• Effective mRNA Protection by Poly(L-Ornithine) Synergizes with Endosomal Escape Functionality of a Charge-Conversion Polymer Toward Maximizing mRNA Introduction Efficiency.

  2022cited by this paper
• Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.

  2022cited by this paper
• The role of lipid components in lipid nanoparticles for vaccines and gene therapy

  2022cited by this paper
• The dawn of mRNA vaccines: The COVID-19 case

  2021cited by this paper
• Viral vector platforms within the gene therapy landscape

  2021cited by this paper
• Lipid nanoparticles for mRNA delivery

  2021cited by this paper
• Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

  2021cited by this paper
• Polymeric Delivery of Therapeutic Nucleic Acids.

  2021cited by this paper
• Self-assembled mRNA vaccines

  2021cited by this paper
• mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

  2021cited by this paper
• Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

  2021cited by this paper
• PEGylated gene carriers in serum under shear flow.

  2020cited by this paper
• Double Click-Functionalized siRNA Polyplexes for Gene Silencing in Epidermal Growth Factor Receptor-Positive Tumor Cells.

  2020cited by this paper
• Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach.

  2020cited by this paper
• Polymeric Nanoparticles with Neglectable Protein Corona.

  2020cited by this paper
• CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

  2020cited by this paper
• PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production.

  2020cited by this paper
• Using Large Datasets to Understand Nanotechnology

  2019cited by this paper
• Virus‐inspired and mimetic designs in non‐viral gene delivery

  2019cited by this paper
• Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging

  2019cited by this paper
• Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target.

  2019cited by this paper
• Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

  2018cited by this paper
• Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

  2018cited by this paper
• Efficient Shielding of Polyplexes Using Heterotelechelic Polysarcosines

  2018cited by this paper
• A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation.

  2018cited by this paper
• PECAM‐1 directed re‐targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E‐mediated uptake

  2018cited by this paper
• Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles

  2017cited by this paper
• Shear Effects on Stability of DNA Complexes in the Presence of Serum.

  2017cited by this paper
• Effect of shear stress on structure and function of polyplex micelles from poly(ethylene glycol)-poly(l-lysine) block copolymers as systemic gene delivery carrier.

  2017cited by this paper
• Fluorinated PEG-Polypeptide Polyplex Micelles Have Good Serum-Resistance and Low Cytotoxicity for Gene Delivery.

  2017cited by this paper
• Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA Nanoparticles

  2017cited by this paper
• Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene

  2017cited by this paper
• Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).

  2016cited by this paper
• Understanding the Kinetics of Protein–Nanoparticle Corona Formation

  2016cited by this paper
• Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.

  2016cited by this paper
• Peptide GE11–Polyethylene Glycol–Polyethylenimine for targeted gene delivery in laryngeal cancer

  2015cited by this paper
• Impact of molecular weight and degree of conjugation on the thermodynamics of DNA complexation and stability of polyethylenimine-graft-poly(ethylene glycol) copolymers.

  2015cited by this paper
• Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond).

  2015cited by this paper
• Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses

  2015cited by this paper
• Enhanced tumor-targeted gene delivery by bioreducible polyethylenimine tethering EGFR divalent ligands.

  2015cited by this paper
• Enhanced Performance of Plasmid DNA Polyplexes Stabilized by a Combination of Core Hydrophobicity and Surface PEGylation.

  2014cited by this paper
• Introducing PeptoPlexes: polylysine-block-polysarcosine based polyplexes for transfection of HEK 293T cells.

  2014cited by this paper
• Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics.

  2014cited by this paper
• PEGylated chitosan complexes DNA while improving polyplex colloidal stability and gene transfection efficiency.

  2013cited by this paper
• Synthesis of polyethylenimine-based nanocarriers for systemic tumor targeting of nucleic acids.

  2013cited by this paper
• Tethered PEG Crowdedness Determining Shape and Blood Circulation Profile of Polyplex Micelle Gene Carriers

  2013cited by this paper
• Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles

  2013cited by this paper
• Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.

  2013cited by this paper
• Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.

  2012cited by this paper
• Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses.

  2012cited by this paper
• Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies.

  2012cited by this paper
• Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona.

  2012cited by this paper
• In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers.

  2011cited by this paper
• Pluronic-based cationic block copolymer for forming pDNA polyplexes with enhanced cellular uptake and improved transfection efficiency.

  2011cited by this paper
• A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma.

  2011cited by this paper
• Physicochemical and Biological Evaluation of siRNA Polyplexes Based on PEGylated Poly(amido amine)s

  2011cited by this paper
• Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding.

  2011cited by this paper
• The evolution of the protein corona around nanoparticles: a test study.

  2011cited by this paper
• Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms.

  2010cited by this paper
• Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

  2010cited by this paper
• Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene delivery.

  2010cited by this paper
• Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding.

  2008cited by this paper
• Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking.

  2008cited by this paper
• Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

  2008cited by this paper
• PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors.

  2008cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

  2007cited by this paper
• Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.

  2007cited by this paper
• Cyclic RGD Peptide-Conjugated Polyplex Micelles as a Targetable Gene Delivery System Directed to Cells Possessing αvβ3 and αvβ5 Integrins

  2007cited by this paper
• Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo.

  2005cited by this paper
• PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.

  2005cited by this paper

• Modulating mRNA carrier efficacy through the molecular catwalk of ionizable nitrogens in lipidic domains.

  2026cites this paper
• Hydrophobic Refinement of Polarity-Switchable Lipo-Xenopeptides Modulates Endosomal Escape and Enhances mRNA Delivery In Vitro and In Vivo.

  2026cites this paper